Dpano – Acinta Pharmaceuticals

Registered App ID 3223911 Class 5 Word

Trademark information

IP India · live record
Application ID
3223911
Status
Registered
Sub status
Not Applicable
Date of application
31 March 2016
Classes
5
Type
Word
Proprietor
Acinta Pharmaceuticals Private 141, 14 Th Floor, Atalanta Building, Nariman Point, Mumbai 400001.
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
Branch Office
IP office
Mumbai
Used since
—
Valid / upto
31 March 2036

Goods & services

Class 5

Class 5MEDICINAL, PHARMACEUTICAL, AYURVEDIC PREPARATIONS AND SUBSTANCES, HERBAL PREPARATIONS FOR MEDICINAL USE, DIETETIC SUBSTANCES ADAPTED FOR MEDICINAL USE, MEDICATED CONFECTIONARY, MEDICATED OIL

PR details

ACINTA PHARMACEUTICALS PVT. LTD, 141, 14TH FLOOR, ATALANTA BUILDING, NARIMAN POINT, MUMBAI 400001., A COMPANY INCORPORATED UNDER THE COMPANIES ACT, 1956 (INDIAN NATIONAL), MANUFACTURERS AND TRADING MERCHANTS, (Body Incorporate)

Uploaded documents

Sign in to open
1 Additional Representation Sheet 31 Mar 2016
1 Power of Attorney 31 Mar 2016
1 TM-1 31 Mar 2016
2 Additional Representation Sheet 31 Mar 2016
2 Power of Attorney 31 Mar 2016
2 TM-1 31 Mar 2016
3 Additional Representation Sheet 31 Mar 2016
3 Power of Attorney 31 Mar 2016
3 TM-1 31 Mar 2016
4 Reply to Exam Report (MIS-R) 06 Oct 2016
5 Journal Copy 29 Jan 2019
6 Certificate 27 Mar 2019
7 TM-R(RENEWAL OF TRADE MARK) 17 Mar 2026

Correspondence and notices

1 Hearing Notice (Show Cause) 7013294 · 3345779 19 Sep 2018
2 Tribunal Accepted Notice for : 3223911 7225710 · 3371381 02 Nov 2018
3 O3 NOTICE 21763055 · 7615050 07 Feb 2026
4 RENEWAL INTIMATION LETTER 22145617 20 Mar 2026

Frequently asked questions

Dpano was applied for on 31 March 2016.

The application was filed by Acinta Pharmaceuticals.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Dpano is 3223911.

Trademark attorney Vishesh And Associates.